2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92546°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
½ÅÁ¦Ç° ¿¬±¸°³¹ß ÅõÀÚ 90%, ±âÈÄ ±â¼ú¿¡ ÁýÁß (2024-06-04)
¾È·¦ V3 ¸ð¹ÙÀÏ ½ÃÅ¥¸®Æ¼, ¡®AV-TEST¡¯ ¸¸Á¡ (2024-12-04)
ÃæºÏ´ë, ù ¾çÀÚÄÄÇ»ÅÍ ¡®IQM ½ºÆÄÅ©¡¯ ¼³Ä¡ÇÑ´Ù (2024-12-04)
¼¼½ºÄÚ ¡®»ì±ÕON Á¤¼ö±â¡¯... »ì±Õ °úÇп¡ ¹Ì¼¼ÇÃ¶ó½ºÆ½ Á¦°Å±î... (2024-05-30)
Saint-Denis Hospital Center Implements Masimo SafetyNet Tele... (2024-09-13)
¿£¾¾¼ÒÇÁÆ®, ±¹³»¡¤À¯·´ °³¹ß ½ºÆ©µð¿À¿Í ±Û·Î¹ú ÆÛºí¸®½Ì °è¾à (2024-12-16)
»ï¼ºÀüÀÚ-¿À¶Ñ±â, ¶óÀÌÇÁ½ºÅ¸ÀÏ TV ÀÌ»ö ÇÑÁ¤ÆÇ ±ÂÁî °ø°³ (2024-08-03)
û°¢Àå¾ÖÀÎ 101¸í¿¡ Àΰø´ÞÆØÀ̰ü ¼ö¼ú ¹× ¾ð¾îÀçȰġ·á Áö¿ø (2024-09-25)
¡®½ºÆäÀÎ ÆÐ¹Ð¸®¡¯ À±À̳ª-´Ù´Ï¿¤, ŸÆÄ½º ½ºÅ¸ÀÏ ÇÑ½Ä ¼Ò°³ (2024-11-11)
¡®³ª´Â SOLO¡¯ 22±â °áÈ¥ Ä¿ÇÃÀº ±¤¼ö-¿µÀÚ¿´´Ù (2024-10-13)
¼¼¿¬Å×Å©, È­ÀÌÆ® LED Àû¿ë ±Û·Î¹ú¼ÅÅÍ IP Ä«¸Þ¶ó Ãâ½Ã (2024-04-26)
Á¶¼±¡¤ÇØ¿î ºÐ¾ß ¡®Åº¼Ò¹èÃâ °ü¸®¡¯ ±¹Á¦Ç¥ÁØ ¸¸µç´Ù (2024-10-25)
º¸½ºÅÏ ´ÙÀ̳»¹Í½º ¾ÆÆ²¶ó½º ÀÛ¾÷ ¿µ»ó ÇØ¿Ü ¹Ìµð¾îµµ ÁÖ¸ñ (2024-11-06)
SLB provides update on planned acquisition of ChampionX (2025-03-09)
Àü ¼¼°è ÇÑ·ù µ¿È£È¸, Çѱ¹ ¹®È­¿Í ÇÔ²² ºû³ª´Ù (2024-11-18)
µ¿¿øF&B, ±¹³» ÃÖÃʷΠģȯ°æ Æ÷ÀåÀç ¡®¹Ì¼¼¹ßÆ÷Çʸ§¡¯ µµÀÔ (2024-10-20)
Protagonist and Takeda Announce Positive Topline Results fro... (2025-03-15)
µ¿¾ÆÁ¦¾à, °¡±×¸° À¯ÀÚ¹ÎÆ® Çâ Ãâ½Ã (2023-10-30)
Ç»Àü ±¹¾Ç ±×·ì ºñ´Ü, ¹Ì±¹ ¼­ºÎ ¼øÈ¸°ø¿¬ (2024-10-26)
½ÅÇÑÅõÀÚÁõ±Ç, ½Ã´Ï¾î Àü¿ë »ó´ã¼¾ÅÍ ½Å¼³ (2024-09-21)
¡®TH Growth Strategy + Deal¡¯ to Drive Sustained Value Creat... (2025-07-04)
¸ñÀûÇü ÆíÀÇÁ¡ ¹æ¹® 5%p Áõ°¡... ÀÏ»óÀû À庸±â °ø°£ ¿ªÇÒ (2024-08-29)
Å״Ͻº, ÇÇŬº¼, ºüµ¨ µî ÀÌ»ö½ºÆ÷Ã÷µµ ¿Â¶óÀÎ ¿¹¾àÀ¸·Î (2024-09-04)
Çö´ëÀÚµ¿Â÷, ±Û·Î¹ú ºê·£µå °¡Ä¡ 230¾ï ´Þ·¯ ´Þ¼º (2024-10-15)
Aster Guardians Global Nursing Award Announces Top 10 Finali... (2024-10-21)
       [ÀÌÀü][1]....[417][418][419][420][421][422][423][424][425]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..